Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 6905-6913
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6905
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.6905
Table 5 Molecular pathology of gastric cancer n (%)
| Variable | Age ≤45 yr(n = 202) | Age > 45 yr(n = 1456) | P value |
| p53 | < 0.001 | ||
| Negative | 123 (60.9) | 681 (46.8) | |
| Positive | 44 (21.8) | 560 (38.5) | |
| MSI | 0.006 | ||
| Stable | 85 (42.1) | 566 (38.9) | |
| MSI-L | 4 (2.0) | 43 (3.0) | |
| MSI-H | 1 (0.5) | 79 (5.4) | |
| HER-2 status | 0.006 | ||
| Negative | 78 (38.6) | 528 (36.3) | |
| Positive | 6 (3.0) | 125 (8.6) | |
| EGFR status | 0.899 | ||
| Negative | 94 (46.5) | 674 (46.3) | |
| Positive | 12 (5.9) | 99 (6.8) |
- Citation: Seo JY, Jin EH, Jo HJ, Yoon H, Shin CM, Park YS, Kim N, Jung HC, Lee DH. Clinicopathologic and molecular features associated with patient age in gastric cancer. World J Gastroenterol 2015; 21(22): 6905-6913
- URL: https://www.wjgnet.com/1007-9327/full/v21/i22/6905.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i22.6905